Nora Franceschini Selected Research

Glucose (Dextrose)

1/2024	Multiple cardiovascular risk factor care in 55 low- and middle-income countries: A cross-sectional analysis of nationally-representative, individual-level data from 280,783 adults.
1/2023	Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population.
1/2022	Association of protein function-altering variants with cardiometabolic traits: the strong heart study.
1/2021	Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study.
1/2020	Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose.
10/2018	Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk.
7/2016	Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin.
9/2013	Genetic variants associated with fasting glucose and insulin concentrations in an ethnically diverse population: results from the Population Architecture using Genomics and Epidemiology (PAGE) study.
4/2011	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nora Franceschini Research Topics

Disease

22	Hypertension (High Blood Pressure) 01/2024 - 01/2007
17	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2009
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 04/2011
11	Atherosclerosis 11/2023 - 01/2009
11	Chronic Renal Insufficiency 01/2023 - 02/2008
9	Albuminuria 01/2023 - 06/2005
8	Coronary Disease (Coronary Heart Disease) 01/2023 - 05/2012
7	Insulin Resistance 12/2023 - 01/2011
7	Heart Failure 01/2023 - 05/2012
6	Neoplasms (Cancer) 05/2024 - 10/2012
5	Inflammation (Inflammations) 11/2023 - 09/2012
5	Proteinuria 04/2013 - 02/2006
4	Kidney Diseases (Kidney Disease) 05/2024 - 02/2006
4	Diabetes Mellitus 12/2023 - 11/2008
4	Ischemic Stroke 11/2023 - 01/2016
4	Stroke (Strokes) 12/2021 - 04/2012
3	Sickle Cell Trait 11/2023 - 03/2017
3	Obesity 11/2022 - 10/2008
3	Infections 12/2021 - 04/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2016
3	Orthostatic Hypotension (Postural Hypotension) 09/2012 - 12/2010
3	Acquired Immunodeficiency Syndrome (AIDS) 08/2009 - 04/2005
2	Renal Insufficiency (Renal Failure) 11/2023 - 03/2004
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2016
2	COVID-19 12/2022 - 07/2021
2	Chronic Disease (Chronic Diseases) 12/2022 - 08/2014
2	Genetic Risk Score 01/2022 - 12/2014
2	Isolated Systolic Hypertension 01/2022 - 01/2019
2	Vascular Calcification 11/2019 - 01/2018
2	Premature Birth (Birth, Premature) 01/2019 - 06/2005
2	Body Weight (Weight, Body) 11/2017 - 01/2016
2	Lung Neoplasms (Lung Cancer) 10/2017 - 12/2013
2	Gout 07/2014 - 05/2013
2	Hyperuricemia 07/2014 - 05/2013
2	Tobacco Use Disorder (Nicotine Dependence) 05/2014 - 12/2013
2	Hepatitis C 01/2009 - 04/2005
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2006 - 03/2003
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2023
1	Cerebral Hemorrhage 11/2023
1	Hemolysis 11/2023

Drug/Important Bio-Agent (IBA)

15	CreatinineIBA 11/2023 - 01/2009
10	AlbuminsIBA 11/2023 - 06/2005
9	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 04/2011
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2015
7	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 05/2012
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2009
5	Blood Proteins (Serum Proteins)IBA 11/2023 - 10/2012
5	CholesterolIBA 01/2023 - 01/2012
5	Polymethyl Methacrylate (Sol)IBA 12/2022 - 11/2017
5	Triglycerides (Triacylglycerol)IBA 12/2014 - 11/2008
4	C-Reactive ProteinIBA 01/2023 - 09/2012
4	oxidized low density lipoproteinIBA 01/2023 - 04/2012
4	LipidsIBA 11/2022 - 04/2011
4	Insulin (Novolin)FDA Link 01/2022 - 01/2007
4	HDL LipoproteinsIBA 01/2021 - 11/2008
4	HDL CholesterolIBA 01/2018 - 01/2012
3	Apolipoprotein L1IBA 05/2024 - 01/2021
3	Apolipoproteins E (ApoE)IBA 01/2024 - 12/2016
3	RNA (Ribonucleic Acid)IBA 10/2023 - 04/2005
3	Uric Acid (Urate)IBA 01/2021 - 05/2013
3	Cystatin CIBA 01/2016 - 01/2008
2	NucleotidesIBA 05/2024 - 10/2023
2	Transcription Factors (Transcription Factor)IBA 01/2024 - 01/2009
2	Hormones (Hormone)IBA 12/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 11/2023 - 03/2017
2	Apolipoproteins B (ApoB)IBA 01/2023 - 12/2016
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 04/2012
2	SaltsIBA 01/2023 - 11/2012
2	Lipoprotein(a)IBA 01/2022 - 05/2012
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 04/2013
2	SodiumIBA 10/2018 - 01/2014
2	Messenger RNA (mRNA)IBA 05/2017 - 10/2015
2	P-2 (P 2)IBA 02/2016 - 12/2014
2	Serum AlbuminIBA 01/2016 - 02/2006
2	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2015 - 05/2013
2	LDL CholesterolIBA 02/2015 - 02/2014
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2014 - 12/2013
2	Cinacalcet (Sensipar)FDA Link 11/2004 - 08/2003
1	Blood Glucose (Blood Sugar)IBA 01/2024
1	InterferonsIBA 01/2024
1	ABO Blood-Group SystemIBA 01/2024
1	3' Untranslated Regions (3' UTR)IBA 01/2024
1	CytokinesIBA 12/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2023
1	Complement Factor D (Factor D)IBA 12/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2023
1	LeptinIBA 12/2023
1	GhrelinIBA 12/2023
1	ResistinIBA 12/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2023
1	ChemokinesIBA 11/2023
1	Hepatitis A Virus Cellular Receptor 1IBA 11/2023
1	Erythropoietin FDA Link 11/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2023
1	Heme Oxygenase-1IBA 11/2023

Therapy/Procedure

9	Therapeutics 01/2024 - 02/2007
3	Precision Medicine 01/2023 - 01/2021
2	Ambulatory Care (Outpatient Care) 07/2021 - 08/2014
2	Highly Active Antiretroviral Therapy (HAART) 01/2009 - 04/2005